Published in Cancer Weekly, February 3rd, 1997
To assess the combination of tacrolimus combined with a reduced dose schedule of methotrexate to prevent acute GVHD, Donna Przepiorka, M.D., Ph.D., the University of Texas M.D. Anderson Cancer Center, Houston, Texas, and colleagues studied 30 adults with leukemia or lymphoma undergoing marrow transplantation from HLA-compatible unrelated donors ("Tacrolimus and Minidose Methotrexate for Prevention of Acute Graft-Versus-Host Disease after Matched Unrelated Donor Marrow...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.